Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials
Pharmaceutical Medicine · 2024-07 · 38 (4) · 261-276
DOI: 10.1007/s40290-024-00529-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Medicine, online erschienen am 09.07.2024. Verfasst von Gareth Baynam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rare Care Centre, Perth Children's Hospital, Perth, WA, Australia. Hauptthemen laut MEDLINE: Rare Diseases, Clinical Trials as Topic, Health Services Accessibility. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Rare Care Centre, Perth Children's Hospital, Perth, WA, Australia.
- Genomics England, London, UK.
- HealthWeb Solutions, London, UK.
- School of Health Studies, University of Western Ontario, London, ON, Canada.
- Uncommon Cures, Washington, DC, USA.
- Stanford Center for Biomedical Ethics, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Anne Pariser
Zitieren
APA
Baynam, G., Baker, S., Steward, C., Summar, M., Halley, M., & Pariser, A. (2024). Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials. Pharmaceutical Medicine, 38(4), 261-276. https://doi.org/10.1007/s40290-024-00529-8
Vancouver
Baynam G, Baker S, Steward C, Summar M, Halley M, Pariser A. Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials. Pharmaceutical Medicine. 2024;38(4):261-276. doi:10.1007/s40290-024-00529-8
BibTeX
@article{Baynam2024,
author = {Baynam, Gareth and Baker, Simeón and Steward, Charles and Summar, Marshall and Halley, Meghan and Pariser, Anne},
title = {Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials},
journal = {Pharmaceutical Medicine},
year = {2024},
volume = {38},
number = {4},
pages = {261--276},
doi = {10.1007/s40290-024-00529-8}
}
EUVIMED